T1	Entity 0 19	Methionine synthase
T2	SNP 20 26	A2756G
R1	SNP_coupled_gene Arg1:T2 Arg2:T1	
T3	Association 58 62	risk
E1	Association:T3 snp_int:T2
T4	Spec 78 91	meta-analysis
R2	Speculation_marker Arg1:E1 Arg2:T4	
T5	Entity 119 122	MTR
R3	Equiv Arg1:T5 Arg2:T1	
T6	SNP 142 148	A2756G
R4	SNP_coupled_gene Arg1:T6 Arg2:T5	
T7	Association 172 176	risk
E2	Association:T7 bc:T8 snp_int:T6
T8	Cancer 191 204	breast cancer
T9	SNP 331 337	A2756G
T10	Spec 293 303	estimation
T11	Association 311 322	association
E3	Association:T11 snp_int:T9 bc:T12
R5	Speculation_marker Arg1:E3 Arg2:T10	
T12	Cancer 342 355	breast cancer
T13	Entity 482 485	MTR
T14	SNP 486 492	A2756G
R6	SNP_coupled_gene Arg1:T14 Arg2:T13	
T15	Spec 447 457	estimating
T16	Association 462 473	association
E4	Association:T16 snp_int:T14 bc:T17
R7	Speculation_marker Arg1:E4 Arg2:T15	
R8	Equiv Arg1:T9 Arg2:T14	
T17	Cancer 497 510	breast cancer
T18	Spec 677 686	suggested
T19	Level 701 715	no significant
T20	Association 716 727	association
E5	Association:T20 snp_int:T21 bc:T22
R9	Level_marker Arg1:E5 Arg2:T19	
A1	Level E5 Low
T21	SNP 736 742	A2756G
T22	Cancer 747 760	breast cancer
R10	Speculation_marker Arg1:E5 Arg2:T18	
T23	Association 1036 1040	risk
E6	Association:T23 snp_int:T26 bc:T22
A2	Effect_Type E6 Decrease
T24	Effect_Type 1026 1035	decreased
R11	Effect_type_marker Arg1:E6 Arg2:T24	
T25	Entity 1044 1054	Caucasians
T26	SNP 736 742	A2756G
T27	Entity 995 1003	G allele
R12	SNP_allele Arg1:T26 Arg2:T27	
R13	Population_assignment Arg1:T26 Arg2:T25	
T28	Entity 878 904	Hardy-Weinberg equilibrium
T30	Entity 1056 1058	PB
T31	Entity 1060 1076	population-based
R15	Equiv Arg1:T31 Arg2:T30	
T32	Entity 1092 1105	large studies
T33	Entity 1056 1058;1078 1086	PB subgroup
R16	Risk_Factor Arg1:T26 Arg2:T33	
R17	Risk_Factor Arg1:T26 Arg2:T32	
R18	Member Arg1:T6 Arg2:T26	
R19	Equiv Arg1:T6 Arg2:T21	
T34	Neg 1128 1139	disappeared
T35	Association 1115 1127	associations
E7	Association:T35 bc:T22 snp_int:T37
R20	Negation_marker Arg1:E7 Arg2:T34	
T36	Entity 1146 1177	removing the studies not in HWE
T37	SNP 736 742	A2756G
R21	SNP_allele Arg1:T37 Arg2:T27	
R22	Risk_Factor Arg1:T37 Arg2:T36	
R23	Risk_Factor Arg1:T37 Arg2:T25	
R24	Risk_Factor Arg1:T37 Arg2:T30	
R25	Member Arg1:T6 Arg2:T37	
T38	Entity 1227 1240	small studies
T39	Effect_Type 1199 1208	increased
T40	Association 1209 1213	risk
E8	Association:T40 bc:T22 snp_int:T41
A3	Effect_Type E8 Increase
R26	Effect_type_marker Arg1:E8 Arg2:T39	
T41	SNP 736 742	A2756G
R27	Risk_Factor Arg1:T41 Arg2:T38	
R28	Population_assignment Arg1:T41 Arg2:T25	
R29	Risk_Factor Arg1:T41 Arg2:T33	
T42	Entity 1174 1177	HWE
R30	Equiv Arg1:T42 Arg2:T28	
R14	SNP_allele Arg1:T41 Arg2:T27	
R31	Member Arg1:T6 Arg2:T26	
T29	Entity 1283 1286	MTR
T43	SNP 1287 1293	A2756G
R32	SNP_coupled_gene Arg1:T43 Arg2:T29	
T44	Neg 1310 1313	not
T45	Association 1314 1324	associated
E9	Association:T45 snp_int:T29 bc:T46 snp_int2:T43
R33	Negation_marker Arg1:E9 Arg2:T44	
T46	Cancer 1356 1369	breast cancer
T47	Spec 1270 1277	suggest
R34	Speculation_marker Arg1:E9 Arg2:T47	
T48	Effect_Type 1390 1399	decreased
T49	Association 1400 1404	risk
E10	Association:T49 
A4	Effect_Type E10 Decrease
R35	Effect_type_marker Arg1:E10 Arg2:T48	
T53	Effect_Type 1455 1464	increased
T54	Association 1465 1469	risk
E11	Association:T54 
A5	Effect_Type E11 Increase
R36	Effect_type_marker Arg1:E11 Arg2:T53	
T55	Spec 1501 1515	selection bias
R37	Speculation_marker Arg1:E11 Arg2:T55	
R38	Speculation_marker Arg1:E10 Arg2:T55	
R39	Equiv Arg1:E10 Arg2:E6	
R40	Equiv Arg1:E11 Arg2:E8	
T50	Spec 1487 1493	may be
R41	Speculation_marker Arg1:T55 Arg2:T50	
T51	Entity 142 143;147 148	A G
R42	Nucleotide_substitution Arg1:T6 Arg2:T51	
T52	Entity 331 332;336 337	A G
R43	Nucleotide_substitution Arg1:T9 Arg2:T52	
T56	Entity 486 487;491 492	A G
R44	Nucleotide_substitution Arg1:T14 Arg2:T56	
T57	Entity 736 737;741 742	A G
R45	Nucleotide_substitution Arg1:T26 Arg2:T57	
R46	Nucleotide_substitution Arg1:T21 Arg2:T57	
R47	Nucleotide_substitution Arg1:T41 Arg2:T57	
R48	Nucleotide_substitution Arg1:T37 Arg2:T57	
T58	Entity 1287 1288;1292 1293	A G
R49	Nucleotide_substitution Arg1:T43 Arg2:T58	
